INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New precision drug targets genetic driver in tough cancers
Disease control CompletedThis study tested a new targeted pill called RLY-4008 in people with advanced cancers, mainly a type of bile duct cancer, that have specific changes in a gene called FGFR2. The main goals were to find a safe dose and see if the drug could shrink tumors. It was for patients whose …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Bubble-Popping ultrasound could boost cancer treatment
Diagnosis CompletedThis study tested a special ultrasound scan that uses tiny gas bubbles to see inside liver tumors. The goal was to see if this scan could predict how well a targeted radiation treatment would work for bile duct cancer. Researchers also tested if using the ultrasound to 'pop' thes…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Feb 25, 2026 15:07 UTC